Method for producing 2,2-difluoroethylamine derivative by amide hydrogenation
View Patent ↗Process for preparing 2,2-difluoroethylamine derivatives, wherein compounds of the general formula (IV) are reduced to the corresponding 2,2-difluoroethylamine derivatives of the general formula (III), where the A radical is as defined in the description:
1. A process for preparing a 2,2-difluoroethylamine derivative, comprising reducing a 2,2-difluoroacetamide derivative of formula (IV) to the corresponding 2,2-difluoroethylamine derivative of formula (III):
by using a reducing agent which is selected from LiAlH 4 , LiAlH(O-tert-butyl) 3 , LiAlH(O-methyl) 3 , NaAlEt 2 H 2 , borohydrides, BH 3 , 9-borabicyclo[3.3.1]nonane, disiamylborane, AlH 3 , DIBAL-H (AlH(isobutyl) 2 ), or hydrides of silicon hydrides of the formula
H—Si—R 3
where R—is H, optionally substituted alkyl, optionally substituted phenyl or chlorine; and
where the A radical in formulae (III) and (IV) is 6-fluoropyrid-3-yl, 6-chloropyrid-3-yl, 6-bromopyrid-3-yl, 6-methylpyrid-3-yl, 6-trifluoromethylpyrid-3-yl, 6-trifluoromethoxypyrid-3-yl, 6-chloro-1,4-pyridazin-3-yl, 6-methyl-1,4-pyridazin-3-yl, 2-chloro-1,3-thiazol-5-yl or 2-methyl-1,3-thiazol-5-yl, 2-chloropyrimidin-5-yl, 2-trifluoromethylpyrimidin-5-yl, 5,6-difluoropyrid-3-yl, 5-chloro-6-fluoropyrid-3-yl, 5-bromo-6-fluoropyrid-3-yl, 5-iodo-6-fluoropyrid-3-yl, 5-fluoro-6-chloropyrid-3-yl, 5,6-dichloropyrid-3-yl, 5-bromo-6-chloropyrid-3-yl, 5-iodo-6-chloropyrid-3-yl, 5-fluoro-6-bromopyrid-3-yl, 5-chloro-6-bromopyrid-3-yl, 5,6-dibromopyrid-3-yl, 5-fluoro-6-iodopyrid-3-yl, 5-chloro-6-iodopyrid-3-yl, 5-bromo-6-iodopyrid-3-yl, 5-methyl-6-fluoropyrid-3-yl, 5-methyl-6-chloropyrid-3-yl, 5-methyl-6-bromopyrid-3-yl, 5-methyl-6-iodopyrid-3-yl, 5-difluoromethyl-6-fluoropyrid-3-yl, 5-difluoromethyl-6-chloropyrid-3-yl, 5-difluoromethyl-6-bromopyrid-3-yl or 5-difluoromethyl-6-iodopyrid-3-yl.
2. The process according to claim 1 , wherein the A radical in formula (IV) and (III) is 6-fluoropyrid-3-yl, 6-chloropyrid-3-yl, 6-bromopyrid-3-yl, 6-chloro-1,4-pyridazin-3-yl, 2-chloro-1,3-thiazol-5-yl, 2-chloropyrimidin-5-yl, 5-fluoro-6-chloropyrid-3-yl, 5,6-dichloropyrid-3-yl, 5-bromo-6-chloropyrid-3-yl, 5-fluoro-6-bromopyrid-3-yl, 5-chloro-6-bromopyrid-3-yl, 5,6-dibromopyrid-3-yl, 5-methyl-6-chloropyrid-3-yl, 5-chloro-6-iodopyrid-3-yl or 5-difluoromethyl-6-chloropyrid-3-yl.
3. The process according to claim 1 , wherein the A radical in formula (IV) and (III) is 6-chloropyrid-3-yl, 6-bromopyrid-3-yl, 6-chloro-1,4-pyridazin-3-yl, 2-chloro-1,3-thiazol-5-yl, 5-fluoro-6-chloropyrid-3-yl or 5-fluoro-6-bromopyrid-3-yl.
4. The process according to claim 1 , wherein the reducing agent is a borohydride, in gaseous form or in solution.
5. The process according to claim 1 , wherein the reducing agent is borohydride, which is prepared in situ by reacting (i) hydridic boron salt with a Lewis acid, Brønsted acid, iodine, bromine or chlorine or (ii) boron halide with NaH or LiAlH 4 ,
wherein the hydridic boron salt is selected from the group consisting of LiBH 4 , NaBH 4 and KBH 4 , the Lewis acid is selected from the group consisting of boron halide, aluminium halide and iron halide, the Brønsted acid is selected from the group consisting of H 2 SO 4 , HCl and phosphoric acid, and the boron halide is selected from the group consisting of BF 3 , BCl 3 and BBr 3 .
6. The process according to claim 1 , wherein the silicon hydrides of the formula H—Si—R 3 are used together with noble metal catalysts selected from the group consisting of rhodium salts and noble metal complexes.
7. The process according to claim 1 , wherein the A radical in formula (IV) and (III) is 6-chloropyrid-3-yl.